By St. Louis Children’s Hospital Logan is a 7-year-old who not only loves to be around others but is also just one belt away from a black belt in Taekwondo and enjoys playing Minecraft and Roblox. Three years ago, Logan was diagnosed with NF1. For Logan, his NF included the thickening of the optic nerves […]
Tag: collaborators
NF Center Researchers Identify a Potential Combination Therapy for MPNST
Dr. Dana Borcherding, a senior scientist in the laboratory of Dr. Angela Hirbe, recently found that the combination of two drugs targeting different growth control pathways in MPNST cells dramatically decreased tumor growth in mice. In their studies, they combined a TYK2 inhibitor with a MEK inhibitor to achieve this dramatic effect with minimal toxicity. […]
Dr. Yuan Pan Awarded Gilbert Family Foundation Grant to Study Optic Gliomas
Dr. Yuan Pan, Assistant Professor at the University of Texas MD Anderson Cancer Center, was recently awarded a three-year grant from the Gilbert Family Foundation Vision Restoration Initiative to study how NF1 mutations in brain cells called oligodendroglial cells change their interactions with the optic nerve. In this grant, Dr. Pan’s team will work with Dr. Corina Anastasaki, Research […]
Dr. Maloney Awarded IDDRC Pilot Grant to Study Social Behavior Deficits in Mice
Dr. Susan Maloney, Research Assistant Professor in Psychiatry, was recently awarded a one-year grant from the Washington University Intellectual and Developmental Disabilities Research Center (IDDRC) to study social behavior in mice with different Nf1 gene mutations. In this grant proposal, Dr. Maloney will collaborate with Dr. Corina Anastasaki, Research Assistant Professor in Neurology, to identify the autism-related behaviors in Nf1-mutant […]
Major Biomarker Project to Help Identify Cancer Predisposition in NF1 Patients
The Children’s Tumor Foundation (CTF) has announced a groundbreaking 3-year study, which it will fund for nearly $2 million, to determine if a DNA-based blood test can offer better understanding and ultimately earlier diagnosis of cancer predisposition in neurofibromatosis type 1 (NF1) patients. Approximately 7-15% percent of NF1 patients may develop malignant peripheral nerve sheath […]